{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T12:30:42Z","timestamp":1772886642884,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T00:00:00Z","timestamp":1672617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000015","name":"Canadian Cancer Society Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004628","name":"MedImmune","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004628","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008247","name":"University of Otago","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005247","name":"University of British Columbia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005247","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.molmet.2023.101667","type":"journal-article","created":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T03:55:42Z","timestamp":1672890942000},"page":"101667","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Islet amyloid polypeptide does not suppress pancreatic cancer"],"prefix":"10.1016","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8167-1209","authenticated-orcid":false,"given":"Austin J.","family":"Taylor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7703-0887","authenticated-orcid":false,"given":"Evgeniy","family":"Panzhinskiy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2251-7153","authenticated-orcid":false,"given":"Paul C.","family":"Orban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis C.","family":"Lynn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David F.","family":"Schaeffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7523-9433","authenticated-orcid":false,"given":"James D.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1875-3401","authenticated-orcid":false,"given":"Janel L.","family":"Kopp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9262-0586","authenticated-orcid":false,"given":"C. Bruce","family":"Verchere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.molmet.2023.101667_bib1","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.2337\/dc20-0204","article-title":"Association of type 2 diabetes with cancer: a meta-analysis with bias analysis for unmeasured confounding in 151 cohorts comprising 32 million people","volume":"43","author":"Ling","year":"2020","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.molmet.2023.101667_bib2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/ijc.27703","article-title":"Epidemiological evidence of a relationship between type-1 diabetes mellitus and cancer: a review of the existing literature","volume":"132","author":"Gordon-Dseagu","year":"2013","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.molmet.2023.101667_bib3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/sj.bjc.6603571","article-title":"Pancreatic cancer in type 1 and young-onset diabetes: systematic review and meta-analysis","volume":"96","author":"Stevens","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.molmet.2023.101667_bib4","first-page":"219","article-title":"WHO-classification 2000: exocrine pancreatic tumors","volume":"85","author":"Kl\u00f6ppel","year":"2001","journal-title":"Verhandlungen Der Deutschen Gesellschaft Fur Pathologie"},{"issue":"4","key":"10.1016\/j.molmet.2023.101667_bib5","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1053\/j.gastro.2008.01.039","article-title":"Prevalence and clinical profile of pancreatic cancer\u2013associated diabetes mellitus","volume":"134","author":"Pannala","year":"2008","journal-title":"Gastroenterology"},{"issue":"35","key":"10.1016\/j.molmet.2023.101667_bib6","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1200\/JCO.2016.67.4283","article-title":"Obesity and cancer mechanisms: tumor microenvironment and inflammation","volume":"34","author":"Iyengar","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.molmet.2023.101667_bib7","doi-asserted-by":"crossref","first-page":"1993e8","DOI":"10.1002\/ijc.22535","article-title":"Body mass index and pancreatic cancer risk: a meta-analysis of prospective studies","volume":"120","author":"Larsson","year":"2007","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.molmet.2023.101667_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.suronc.2014.02.003","article-title":"Obesity and pancreatic cancer","volume":"23","author":"Preziosi","year":"2014","journal-title":"Surg Oncol"},{"issue":"14","key":"10.1016\/j.molmet.2023.101667_bib9","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1093\/jnci\/djt123","article-title":"Hyperglycemia, insulin resistance, impaired pancreatic \u03b2-cell function, and risk of pancreatic cancer","volume":"105","author":"Wolpin","year":"2013","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.molmet.2023.101667_bib10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4093\/dmj.2020.0250","article-title":"Hyperinsulinemia in obesity, inflammation, and cancer","volume":"45","author":"Zhang","year":"2021","journal-title":"Diabet Metab J"},{"key":"10.1016\/j.molmet.2023.101667_bib11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12943-018-0806-0","article-title":"Insulin\/IGF-driven cancer cell-stroma crosstalk as a novel therapeutic target in pancreatic cancer","volume":"17","author":"Mutgan","year":"2018","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/j.molmet.2023.101667_bib12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40170-022-00282-z","article-title":"Effects of hyperinsulinemia on pancreatic cancer development and the immune microenvironment revealed through single-cell transcriptomics","volume":"10","author":"Zhang","year":"2022","journal-title":"Cancer Metabol"},{"issue":"3","key":"10.1016\/j.molmet.2023.101667_bib13","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cmet.2019.07.003","article-title":"Endogenous hyperinsulinemia contributes to pancreatic cancer development","volume":"30","author":"Zhang","year":"2019","journal-title":"Cell Metabol"},{"issue":"11","key":"10.1016\/j.molmet.2023.101667_bib14","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.metabol.2011.03.019","article-title":"Portal vein and systemic adiponectin concentrations are closely linked with hepatic glucose and lipoprotein kinetics in extremely obese subjects","volume":"60","author":"Magkos","year":"2011","journal-title":"Metab Clin Exp"},{"issue":"12","key":"10.1016\/j.molmet.2023.101667_bib15","first-page":"4491","article-title":"Direct measurement of pulsatile insulin secretion from the portal vein in human Subjects1","volume":"85","author":"Song","year":"2000","journal-title":"J\u00a0Clin ENdocrinol Metab"},{"key":"10.1016\/j.molmet.2023.101667_bib16","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.12977","article-title":"Time-resolved studies define the nature of toxic IAPP intermediates, providing insight for anti-amyloidosis therapeutics","volume":"5","author":"Abedini","year":"2016","journal-title":"Elife"},{"issue":"3","key":"10.1016\/j.molmet.2023.101667_bib17","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2337\/diabetes.48.3.491","article-title":"The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles","volume":"48","author":"Janson","year":"1999","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.molmet.2023.101667_bib18","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1007\/s00125-010-1671-6","article-title":"Toxic oligomers and islet beta cell death: guilty by association or convicted by circumstantial evidence?","volume":"53","author":"Zraika","year":"2010","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.molmet.2023.101667_bib19","doi-asserted-by":"crossref","first-page":"R121","DOI":"10.1530\/JME-17-0105","article-title":"The \u03b2-cell assassin: IAPP cytotoxicity","volume":"59","author":"Raleigh","year":"2017","journal-title":"J\u00a0Mol Endocrinol"},{"issue":"7536","key":"10.1016\/j.molmet.2023.101667_bib20","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nature13910","article-title":"IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in\u00a0vivo","volume":"517","author":"Venkatanarayan","year":"2015","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.molmet.2023.101667_bib21","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1080\/15384101.2015.1121333","article-title":"Novel therapeutic interventions for p53-altered tumors through manipulation of its family members, p63 and p73","volume":"15","author":"Venkatanarayan","year":"2016","journal-title":"Cell Cycle"},{"key":"10.1016\/j.molmet.2023.101667_bib22","first-page":"23","article-title":"Pramlintide, an antidiabetic, is antineoplastic in colorectal cancer and synergizes with conventional chemotherapy","volume":"10","author":"Al-Keilani","year":"2018","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.molmet.2023.101667_bib23","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1210\/jc.2016-2773","article-title":"Measurement of pro-islet amyloid polypeptide (1\u201348) in diabetes and islet transplants","volume":"102","author":"Courtade","year":"2017","journal-title":"J\u00a0Clin ENdocrinol Metab"},{"issue":"8","key":"10.1016\/j.molmet.2023.101667_bib24","first-page":"2822","article-title":"Deficiency of total and nonglycosylated amylin in plasma characterizes subjects with impaired glucose tolerance and type 2 diabetes","volume":"85","author":"M\u00e4kimattila","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.molmet.2023.101667_bib25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF00500385","article-title":"Plasma islet amyloid polypeptide (Amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients","volume":"34","author":"Sanke","year":"1991","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.molmet.2023.101667_bib26","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1006\/bbrc.1998.9308","article-title":"Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin)","volume":"250","author":"Gebre-Medhin","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"issue":"24","key":"10.1016\/j.molmet.2023.101667_bib27","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1101\/gad.943001","article-title":"Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras","volume":"15","author":"Jackson","year":"2001","journal-title":"Genes Devlop"},{"issue":"8","key":"10.1016\/j.molmet.2023.101667_bib28","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1101\/gad.14.8.994","article-title":"Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum","volume":"14","author":"Marino","year":"2000","journal-title":"Genes Devlop"},{"issue":"4","key":"10.1016\/j.molmet.2023.101667_bib29","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1242\/dev.090159","article-title":"Spatiotemporal patterns of multipotentiality in Ptf1a-expressing cells during pancreas organogenesis and injury-induced facultative restoration","volume":"140","author":"Pan","year":"2013","journal-title":"Development"},{"issue":"2","key":"10.1016\/j.molmet.2023.101667_bib30","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/ijo.2009.238","article-title":"Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight","volume":"34","author":"Mack","year":"2010","journal-title":"Int J Obes"},{"issue":"12","key":"10.1016\/j.molmet.2023.101667_bib31","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1111\/bph.13496","article-title":"Amylin structure-function relationships and receptor pharmacology: implications for amylin mimetic drug development","volume":"173","author":"Bower","year":"2016","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.molmet.2023.101667_bib32","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/MPA.0b013e3181c15963","article-title":"Phenotype and genotype of pancreatic cancer cell lines","volume":"39","author":"Deer","year":"2010","journal-title":"Pancreas"},{"issue":"1","key":"10.1016\/j.molmet.2023.101667_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/srep21648","article-title":"MIA PaCa-2 and PANC-1 \u2013 pancreas ductal adenocarcinoma cell lines with neuroendocrine differentiation and somatostatin receptors","volume":"6","author":"Gradiz","year":"2016","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.molmet.2023.101667_bib34","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1083\/jcb.200312135","article-title":"Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in\u00a0vivo","volume":"164","author":"Dacquin","year":"2004","journal-title":"J\u00a0Cell Biol"},{"issue":"1","key":"10.1016\/j.molmet.2023.101667_bib35","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1210\/en.2009-0546","article-title":"Mechanisms of amylin\/leptin synergy in rodent models","volume":"151","author":"Turek","year":"2010","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.molmet.2023.101667_bib36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/00365521.2011.638392","article-title":"Food intake and meal pattern in IAPP knockout mice with and without infusion of exogenous IAPP","volume":"47","author":"Olsson","year":"2012","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"10.1016\/j.molmet.2023.101667_bib37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0196-9781(02)00280-2","article-title":"Endogenous amylin contributes to the anorectic effects of cholecystokinin and bombesin","volume":"24","author":"Mollet","year":"2003","journal-title":"Peptides"},{"issue":"5","key":"10.1016\/j.molmet.2023.101667_bib38","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1172\/JCI116046","article-title":"Cloning, characterization, and expression of a human calcitonin receptor from an ovarian carcinoma cell line","volume":"90","author":"Gorn","year":"1992","journal-title":"J\u00a0Clin Investig"},{"issue":"6 Pt 2","key":"10.1016\/j.molmet.2023.101667_bib39","first-page":"F1110","article-title":"A\u00a0cloned porcine renal calcitonin receptor couples to adenylyl cyclase and phospholipase C","volume":"262","author":"Force","year":"1992","journal-title":"Am J Physiol"},{"issue":"11","key":"10.1016\/j.molmet.2023.101667_bib40","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1210\/en.2007-1735","article-title":"Receptor activity-modifying proteins differentially modulate the G protein-coupling efficiency of amylin receptors","volume":"149","author":"Morfis","year":"2008","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/j.molmet.2023.101667_bib41","first-page":"959","article-title":"Functionally different isoforms of the human calcitonin receptor result from alternative splicing of the gene transcript","volume":"9","author":"Moore","year":"1995","journal-title":"Mol Endocrinol"},{"issue":"6","key":"10.1016\/j.molmet.2023.101667_bib42","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1210\/endo.140.6.6783","article-title":"A\u00a0receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1","volume":"140","author":"B\u00fchlmann","year":"1999","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.molmet.2023.101667_bib43","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1124\/pr.54.2.233","article-title":"International union of pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors","volume":"54","author":"Poyner","year":"2002","journal-title":"Pharmacol Rev"},{"issue":"5","key":"10.1016\/j.molmet.2023.101667_bib44","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1124\/mol.104.008615","article-title":"Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexes","volume":"67","author":"Hay","year":"2005","journal-title":"Mol Pharmacol"},{"issue":"2","key":"10.1016\/j.molmet.2023.101667_bib45","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1210\/endo.134.2.8299557","article-title":"Calcitonin stimulates growth of human prostate cancer cells through receptor-mediated increase in cyclic adenosine 3\u2019,5\u2019-monophosphates and cytoplasmic Ca2+ transients","volume":"134","author":"Shah","year":"1994","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.molmet.2023.101667_bib46","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1677\/ERC-08-0136","article-title":"Calcitonin promotes in\u00a0vivo metastasis of prostate cancer cells by altering cell signaling, adhesion, and inflammatory pathways","volume":"15","author":"Shah","year":"2008","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"10.1016\/j.molmet.2023.101667_bib47","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1677\/JME-07-0036","article-title":"Calcitonin targets extracellular signal-regulated kinase signaling pathway in human cancers","volume":"39","author":"Nakamura","year":"2007","journal-title":"J\u00a0Mol Endocrinol"},{"issue":"6","key":"10.1016\/j.molmet.2023.101667_bib48","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1158\/0008-5472.CAN-06-3362","article-title":"Adrenomedullin is expressed in pancreatic cancer and stimulates cell proliferation and invasion in an autocrine manner via the adrenomedullin receptor, ADMR","volume":"67","author":"Ramachandran","year":"2007","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.molmet.2023.101667_bib49","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ijc.22596","article-title":"Adrenomedullin is induced by hypoxia and enhances pancreatic cancer cell invasion","volume":"121","author":"Keleg","year":"2007","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.molmet.2023.101667_bib50","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jss.2014.11.002","article-title":"The novel tumor angiogenic factor, adrenomedullin-2, predicts survival in pancreatic adenocarcinoma","volume":"197","author":"Hollander","year":"2015","journal-title":"J\u00a0Surg Res"},{"issue":"42","key":"10.1016\/j.molmet.2023.101667_bib51","doi-asserted-by":"crossref","first-page":"E8875","DOI":"10.1073\/pnas.1709123114","article-title":"Systems-level identification of PKA-dependent signaling in epithelial cells","volume":"114","author":"Isobe","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.molmet.2023.101667_bib52","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1748-1716.2011.02273.x","article-title":"Cyclic AMP is both a pro-apoptotic and anti-apoptotic second messenger","volume":"204","author":"Insel","year":"2012","journal-title":"Acta Physiol"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877823000017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877823000017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:32:56Z","timestamp":1761957176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877823000017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":52,"alternative-id":["S2212877823000017"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2023.101667","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Islet amyloid polypeptide does not suppress pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2023.101667","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"101667"}}